Turkey's Competition Council said on Monday it had opened an investigation into 19 pharmaceutical companies to determine whether they had committed legislative violations.
On 9 November, the Council said it was decided to launch inspections of companies, including AstraZeneca, Bayer, GlaxoSmithKline, Johnson & Johnson, Bausch & Lomb, Sanofi and Pfizer. The statement did not include details.
Following an inquiry on the matter, AstraZeneca said the company's policy requires it not to discuss ongoing investigations.
European Commission creates 'single market for medicines'
GlaxoSmithKline, Sanofi and Germany's Merck KGaA said they were cooperating fully with Turkey, but gave no further details.
In a statement, the German chemical company BASF said it was taking into account the checks and committed to high standards of legality and business ethics.
AbbVie, Abdi Ibrahim, Bausch & Lomb, Bayer, Ilko, Johnson & Johnson, Liba, Menarini, Michael Page International, Panasonic, Pfizer, SIFI and World Medicine have not commented.
Follow the channel on